◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

GMO Systematic Investment Grade Credit ETF (INVG) ETF Overview

Name: GMO Systematic Investment Grade Credit ETF (INVG) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · Corporate Bond · DATA UPDATED 2026-08-31

GMO Systematic Investment Grade Credit ETF (INVG) is an exchange-traded fund managed by GMO in the "Corporate Bond" category. It manages roughly $24 million in assets.

The fund is an actively managed ETF that seeks to achieve its investment objective by investing primarily in U.S. investment grade debt securities.

Interactive chart & fund stats →

INVG Fund Statistics

Expense ratio	0.25%
Trailing yield	4.91%
Assets under management	$24 million
Fund category	Corporate Bond
Fund family	GMO
Inception	2025-06-03

The live price chart, fund profile and news are in the interactive INVG viewer.

Other Companies in Corporate Bond

FEIG · Northern Trust ESG & Climate Investment Grade Corporate Core ETF — $48 million
BBCB · JPMorgan BetaBuilders USD Investment Grade Corporate Bond ETF — $45 million
IGCB · TCW Corporate Bond ETF — $41 million
EYEG · AB Corporate Bond ETF — $26 million
MIG · VanEck Moody's Analytics IG Corporate Bond ETF — $19 million
MILK · Pacer US Cash Cows Bond ETF — $19 million
QIG · WisdomTree U.S. Corporate Bond Fund — $17 million
RFCI · ALPS Dynamic Core Income ETF — $16 million

← INVE All “I” companies INVH →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.